SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15826765
Source:
http://linkedlifedata.com/resource/pubmed/id/15826765
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0038952
,
umls-concept:C0074825
,
umls-concept:C0376358
,
umls-concept:C2698872
pubmed:issue
5
pubmed:dateCreated
2005-4-13
pubmed:abstractText
Evidence suggests that the insulin-like growth factor (IGF) family is important in prostate cancer. We evaluate the ability of IGF markers to predict biochemical recurrence-free survival (bRFS) following radical prostatectomy (RRP).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7512719
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Androgens
,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor Binding...
,
http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen
,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0302-2838
pubmed:author
pubmed-author:AudetJean-FrançoisJF
,
pubmed-author:DouvillePierreP
,
pubmed-author:FradetYvesY
,
pubmed-author:HarelFrançoisF
,
pubmed-author:InmanBrant ABA
,
pubmed-author:LacombeLouisL
,
pubmed-author:MeyerFrançoisF
pubmed:issnType
Print
pubmed:volume
47
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
695-702
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15826765-Adenocarcinoma
,
pubmed-meshheading:15826765-Aged
,
pubmed-meshheading:15826765-Androgens
,
pubmed-meshheading:15826765-Biopsy
,
pubmed-meshheading:15826765-Disease-Free Survival
,
pubmed-meshheading:15826765-Follow-Up Studies
,
pubmed-meshheading:15826765-Humans
,
pubmed-meshheading:15826765-Insulin-Like Growth Factor Binding Protein 2
,
pubmed-meshheading:15826765-Male
,
pubmed-meshheading:15826765-Middle Aged
,
pubmed-meshheading:15826765-Neoplasm Recurrence, Local
,
pubmed-meshheading:15826765-Neoplasm Staging
,
pubmed-meshheading:15826765-Predictive Value of Tests
,
pubmed-meshheading:15826765-Prostate-Specific Antigen
,
pubmed-meshheading:15826765-Prostatectomy
,
pubmed-meshheading:15826765-Prostatic Neoplasms
,
pubmed-meshheading:15826765-Quebec
,
pubmed-meshheading:15826765-ROC Curve
,
pubmed-meshheading:15826765-Retrospective Studies
,
pubmed-meshheading:15826765-Tumor Markers, Biological
pubmed:year
2005
pubmed:articleTitle
Insulin-like growth factor binding protein 2: an androgen-dependent predictor of prostate cancer survival.
pubmed:affiliation
Division of Urology, Laval University, CRHDQ, 11 côte du Palais, Québec, QC, Canada G1R 2J6. brantinman@videotron.ca
pubmed:publicationType
Journal Article
,
Comparative Study